Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Megan R McMullenDepartment of Inflammation and Immunity, Cleveland Clinic Research, Cleveland, OH 44195.ORCID 0009-0007-6020-7125
Laura E NagyDepartment of Inflammation and Immunity, Cleveland Clinic Research, Cleveland, OH 44195.ORCID 0000-0002-0580-2809
Zeneng WangCenter for Microbiome and Human Health, Cleveland Clinic Research, Cleveland, OH 44195.ORCID 0000-0002-6455-8228
Stanley L HazenCenter for Microbiome and Human Health, Cleveland Clinic Research, Cleveland, OH 44195.ORCID 0000-0001-7124-6639
J Mark BrownDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland, OH 44195.ORCID 0000-0003-2708-7487
Funding
Project 4 Title: Innate immunity and cell death in ALDP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · 2021 to 2025
$5.0M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · 2023 to 2025
$3.6M
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related DementiaRF1NS133812 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI Jonathan Mark Brown, Feixiong Cheng · 2023 to 2023
$2.3M
Gut Microbe-Derived Lipids Shape Chronic Inflammation in Cardiometabolic DiseaseR01HL179780 · CLEVELAND CLINIC LERNER COM-CWRU · 2025 to 2025
Although strong evidence links the gut microbiome to metabolic disease, the mechanisms linking microbiota to hormonal and metabolic responses to food are not well understood. After a meal, gut bacteria produce a wide array of small molecule, protein, and lipid metabolites originating from bacterial sources. Attributing physiological function to select gut microbe-derived metabolites is critical to understanding diet-microbe-host interactions, and to developing microbiome-inspired therapies to improve human health. Here, we have investigated the role of a poorly annotated class of gut microbiome-derived lipids called
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.